US states, doctors split with CDC on hepatitis B shots for newborns
Major medical associations and state health departments are moving to maintain the standard of universal hepatitis B vaccination at birth, diverging from a recent…
Hepatitis
Liver scarring before treatment for hepatitis C predicts cancer risk
People with hepatitis C who show higher values of liver scarring markers before starting antiviral therapy are significantly more likely to later develop…
Model predicts combo therapy may cure hepatitis C in 2 months
New modeling data predict that bemnifosbuvir and ruzasvir, an experimental combination treatment being developed by Atea Pharmaceuticals for chronic hepatitis C, may…
Gene-editing therapy PBGENE-HBV shows encouraging trial results
PBGENE-HBV, Precision BioSciences’ experimental gene-editing therapy for chronic hepatitis B, showed antiviral activity across three doses, with the highest dose approaching the benchmark…
All spots filled in trial testing Vir’s combo treatment for hepatitis D
Enrollment is now complete for Vir Biotechnology’s global ECLIPSE 1 trial, which is testing the combination treatment of tobevibart and elebsiran in people with chronic…
Hepatitis D therapy RBD1016 wins orphan drug designation in EU
The European Medicines Agency (EMA) has granted orphan drug designation to Suzhou Ribo Life Science’s experimental therapy RBD1016 for hepatitis D. The EMA gives…
Autoimmune hepatitis therapy hits FDA roadblock, future uncertain
Kezar Life Sciences has hit a roadblock in plans to develop zetomipzomib, its experimental treatment for autoimmune hepatitis (AIH). The company has…
US enrollment starts for hepatitis B gene therapy clinical trial
A Phase 1 clinical trial testing PBGENE-HBV, a gene-editing therapy for chronic hepatitis B, is now recruiting patients at Massachusetts General Hospital in…
Liver Foundation honors family who turned diagnosis into giving
A family whose experience with biliary atresia led to an effort to help others navigate the challenges of pediatric liver disease is among those being…
Oregon gets $7.5M US grant to treat HCV with telehealth, peer support
A three-year program in Oregon is receiving a $7.5-million federal grant to improve healthcare for rural residents who use recreational drugs. The program will use…
Recent Posts
- Less invasive Kasai surgery works better for infants with BA: Study
- US states, doctors split with CDC on hepatitis B shots for newborns
- PSC-IBD study shows need for regional management guidelines
- Staying on top of MASH may mean not staying on the transplant list
- Common virus may play a role in ICP development, study finds